StackHaus Research

@stackhauspeps

StackHaus Life 🧬 - Your guide to the StackHaus ecosystem. Bridging the gap between lab research & longevity. For educational purposes only.

Joined December 2025

Pinned
StackHaus Research
@stackhauspeps
Jun 26
3 peptide papers most people missed this month: BPC-157 → acetylcholinesterase BPC-157 → ischemia-reperfusion TB-500 → corneal nerve regeneration + a Sports Medicine category review RUO · PubMed: 42278509, 42204242, 42283548, 41966639
StackHaus Research
@stackhauspeps
Aug 21
Humans produce exactly ONE antimicrobial peptide: LL-37 — the only human cathelicidin. Disrupts bacterial membranes. Activates TLRs/NLRs. 2025: LL-37 exosomes promoted wound healing preclinically. Caveat: serum instability, in vitro data. Delivery = open problem. RUO only.
Made with AI
StackHaus Research
@stackhauspeps
Aug 20
Tirzepatide SURPASS-CVOT (NEJM Dec 2025, PMID 41406444): Vs.
Made with AI
StackHaus Research
@stackhauspeps
Aug 19
A vendor lists 99% purity. A 2024 study tested independently: 7.7% actual. Endotoxin in every purchased vial. What does an HPLC COA actually measure — and what does it miss?
Made with AI
StackHaus Research
@stackhauspeps
Aug 18
Thymosin Alpha-1 has more human RCT data and regulatory approvals than almost any research peptide people talk about. FDA Phase III. Approved in 40+ countries. A 2022 trial showed 75% vs 53% survival in liver failure patients. Why is it never in the conversation?
Made with AI